Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.
Lang J, Zhao X, Wang X, Zhao Y, Li Y, Zhao R, Cheng K, Li Y, Han X, Zheng X, Qin H, Geranpayehvaghei M, Shi J, Anderson GJ, Hao J, Ren H, Nie G.
Lang J, et al. Among authors: qin h.
ACS Nano. 2019 Feb 26;13(2):2176-2189. doi: 10.1021/acsnano.8b08823. Epub 2019 Jan 28.
ACS Nano. 2019.
PMID: 30676731